{
    "title": "113_hr4287",
    "content": "The \"Independent Innovator and Repurposing Act\" may extend the patent term for using biological products. The \"Independent Innovator and Repurposing Act\" allows for a 5-year extension of a patent for using biological products, provided certain conditions are met. The extension must be applied for by the patent owner or their agent, and the patent must not have expired or been previously extended. To extend a patent term for using biological products, the owner must submit an application to the Director with specific details, including the identity of the biological product and the patent, along with proof of independent innovation or ownership by a qualified small business. To extend a patent term for biological products, the owner must submit an application with specific details, including proof of independent innovation or ownership by a qualified small business, and a filed application for commercial marketing under the Public Health Service Act. A minimum of 10 years must have passed since the original submission for investigating the method of use. To extend a patent term for biological products, the owner must submit an application under section 505(i) of the Federal Food, Drug, and Cosmetic Act. The application should include details of activities undertaken with respect to the product and significant dates. The Director will determine eligibility based on the application's representations. The Director determines patent extension eligibility based on application representations. If approved, a 5-year extension certificate is issued and recorded in the patent file. An interim extension may be granted if the patent would expire before a decision is made. The Director determines patent extension eligibility based on application representations. An interim extension may be granted if the patent would expire before a decision is made. The term \"biological product\" is defined in this section. The term \"Director\" refers to the Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office. The term \"independent innovator\" is defined as a person or entity who obtains a method of use patent for a biological product and is not affiliated with the holder of a marketing application approved under the Public Health Service Act. The term \"affiliated\" in the context of the Public Health Service Act refers to any relationship of employment, control, or common ownership, whether direct or indirect. A \"qualified small business\" is defined as an entity with fewer than 500 employees, including employees of affiliates, and not affiliated with the holder of a marketing application approved under the Act. The section applies to any unexpired patent issued before, on, or after the effective date of the Act."
}